First-Time Generic Product Launch
Product launch of a first-time generic product in the glaucoma market was well received and concluded with a 3.6-1 ROI.
Product Launch of New Dosage Strength
Product launch for new dosage strength of an existing product within the SNRI generic market concluded with a 5-1 ROI.
A rare disease company utilized our Tele-Sales team to generate opportunities in just under 1,000 offices over a 12-month period.
Inpatient pharmacy product with declining sales saw a dramatic increase in sales through the first 9 months and consistent growth through the end of the year after engaging Pharma Kinnex.